- Between 1–2% of all pregnancies around the world are affected by pregestational diabetes.
- Pregestational diabetes is considered one of the most challenging medical complications during pregnancy, and it increases the pregnant person’s risk for several potential pregnancy complications.
- The number of people using GLP-1 receptor agonist medications for type 2 diabetes has increased over the last few years.
- Researchers from the Harvard T.H. Chan School of Public Health have now found that medications such as GLP-1 receptor agonists do not increase congenital malformation risk in pregnancy when compared to insulin therapy.
- Scientists believe the number of infants prenatally exposed to these drugs will continue to increase.
Between
Pregestational diabetes is considered one of the
The condition can also increase the risk for potential pregnancy
Pregnant people with type 2 diabetes still need to take their diabetes medications. Over the past few years, the number of people with type 2 diabetes taking
Now, new research from the Harvard T.H. Chan School of Public Health in Boston, MA, reports that the use of
Researchers also observed increased use of these antidiabetic medications throughout the 12-year study period. They believe this suggests the number of infants prenatally exposed to these drugs will continue…
Read the full article here